Login to Your Account



MS Ventures Expands, Moves Early Firms Along Dual Track

By Nuala Moran
Staff Writer

Tuesday, May 21, 2013
LONDON – Merck Serono is enlarging its venture fund from €40 million to €100 million (US$51 million to $128 million) – increasing its capacity to invest in early stage companies, technologies and products that can be shaped up for the company's internal pipeline.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription